Meta AnalysisID 6107
复方丹参滴丸联合针刺治疗急性冠脉综合征：系统评价与Meta分析方案
CRD42022374684
Acute coronary syndrome (ACS) is caused by unstable plaque in the coronary artery， with the rupture of plaque, the patient had severe chest pain in a short time[1-2]。 Compound Danshen Dripping Pills is effective in the t
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Formula: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 6107
- Evidence Id
- 14665
- Core Evidence Id
- 14665
- Source Meta Analysis Id
- 6089
- Herb2 Meta Analysis Id
- HBMA006089
- Crd Id
- CRD42022374684
- Title
- Compound Danshen Dripping Pills combined with Acupuncture in the treatment of acute coronary syndrome：A protocol for systematic review and meta-analysis
- Review Question
- Acute coronary syndrome (ACS) is caused by unstable plaque in the coronary artery， with the rupture of plaque, the patient had severe chest pain in a short time[1-2]。 Compound Danshen Dripping Pills is effective in the treatment of coronary heart disease, myocardial infarction and so on, acupuncture as an adjuvant treatment can reduce the side effects and drug resistance of oral drugs. However, the clinical efficacy of acupuncture combined with Compound Danshen Dripping Pills in the treatment of patients with acute coronary syndrome has not yet been determined. We plan to conduct a systematic review and meta-analysis to summaries the clinical efficacy and safety of acupuncture combined with Compound Danshen Dripping Pills in the treatment of patients with acute coronary syndrome and provide credible evidence for the clinical application and subsequent studies of it
- Study Type Included
- We will include published randomized controlled trials (RCTs) focused on Compound Danshen Dripping Pills or acupuncture for treating ACS
- Condition Being Studied
- Acute coronary syndrome (ACS) is a disease related to myocardial infarction and acute myocardial ischemia，The main cause of the disease is the sudden insufficient blood supply to the coronary artery According to ECG, ACS can be divided into two different types according to whether ST segment is elevated or not，One is ST segment elevation myocardial infarction, the other is non ST segment elevation myocardial infarction .NSTE-ACS can be subdivided into two types，One is unstable angina pectoris (UPA) and the other is non ST segment 2 elevation myocardial infarction.STEMI, the most effective treatment is myocardial reperfusion. For NSTEMI, the key means of treatment is antithrombotic and reperfusion. For the current vascular reperfusion, the most effective method is percutaneous coronary intervention (PCI), With the continuous progress of coronary intervention technology and drug reperfusion treatment, the treatment of ACS has made a breakthrough. However, in the process of clinical treatment, the problems of high mortality and poor prognosis have not been well solved. Therefore, it is important to seek safe and effective supplementary therapies and alternatives treatments for ACSThis systematic review will comprehensively summaries the clinical efficacy and safety of acupuncture combined with Compound Danshen Dripping Pills with acute coronary syndrome.
- Participant
- We will include patients who meet the diagnostic criteria of Western medicine for acute coronary syndrome and set the diagnostic criteria of UAP and NSTEMI with reference to the 2016 guidelines for the diagnosis and treatment of None-ST segment elevation acute coronary syndrome [18]. To formulate the diagnostic criteria of STEMI, refer to the 2019 guidelines for the diagnosis and treatment of acute ST segment elevation myocardial infarction [19]. Treatment, regardless of age, sex, course of disease and race.
- Animal
- Human Disease Modelled
- Intervention
- This study will include interventions in patients who received the Compound Danshen Dripping Pills. Acupuncture points: Xinshu (BL15), Geshu (BL17), Neiguan (PC6), 15~20 mm of straight needles, bring about the desired sensation, use the reinforcing-reducing method, keep the needles for 20 minutes, 10 minutes once.
- Comparator Control
- . We will include studies in which the control group adopted standard treatment (e.g., Secondary prevention of coronary heart disease).
- Main Outcome
- Primary outcomes: the primary outcomes of this study were clinical total effective rate, performance status, and ADRs
- Outcome Measure
- Additional Outcome
- Secondary outcomes: safety of the Acupuncture combined with Compound Danshen Dripping Pills therapies, including adverse events and withdrawals for any reason
- Study Method
- Meta-analysis, Systematic review
- Keyword
- Acupuncture Therapy; Acute Coronary Syndrome; Chest Pain; Coronary Disease; Coronary Vessels; Drug Resistance; Humans; Meta-Analysis as Topic; Myocardial Infarction; Systematic Reviews as Topic; Treatment Outcome; danshen dripping pill
- Contact
- Linlin Zhang [email protected]
- Organisational Affiliation
- 长春中医药大学
- Funding Source
- National Natural Science Foundation of China Grant number(s) <span style=font-size: 14px>State the funder, grant or award number and the date of award</span> 8217150697
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- China
- Review Stage
- Review Ongoing
- First Submission Date
- 2022-11-11
- Registration Date
- 2022-11-21
- Anticipated Start Date
- 2022-12-02
- Anticipated Completion Date
- 2023-01-01
- Title Cn
- 复方丹参滴丸联合针刺治疗急性冠脉综合征：系统评价与Meta分析方案
- Title En
- Compound Danshen Dripping Pills combined with Acupuncture in the treatment of acute coronary syndrome：A protocol for systematic review and meta-analysis
- Bilingual Status
- complete